AIM IMMUNOTECH INC. (AIM) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -14.27M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-14.27M | (m) |
| 2026-03-31 | (m) | $-13.28M | (m) |
| 2025-12-31 | (m) | $-13.96M | (m) |
| 2025-09-30 | (m) | $-15.75M | (m) |
| 2025-06-30 | (m) | $-16.17M | (m) |
| 2025-03-31 | (m) | $-15.21M | (m) |
| 2024-12-31 | (m) | $-17.32M | (m) |
| 2024-09-30 | (m) | $-23.93M | (m) |
| 2024-06-30 | (m) | $-28.05M | (m) |
| 2024-03-31 | (m) | $-31.12M | (m) |
| 2023-12-31 | (m) | $-28.96M | (m) |
| 2023-09-30 | (m) | $-20.77M | (m) |
| 2023-06-30 | (m) | $-19.34M | (m) |
| 2023-03-31 | (m) | $-19.29M | (m) |
| 2022-12-31 | (m) | $-19.45M | (m) |
| 2022-09-30 | (m) | $-20.90M | (m) |
| 2022-06-30 | (m) | $-18.34M | (m) |
| 2022-03-31 | (m) | $-19.37M | (m) |
| 2021-12-31 | (m) | $-19.13M | (m) |
| 2021-09-30 | (m) | $-17.21M | (m) |
| 2021-06-30 | (m) | $-16.70M | (m) |
| 2021-03-31 | (m) | $-14.17M | (m) |
| 2020-12-31 | (m) | $-14.40M | (m) |
| 2020-09-30 | (m) | $-11.66M | (m) |
| 2020-06-30 | (m) | $-11.30M | (m) |
| 2020-03-31 | (m) | $-9.98M | (m) |
| 2019-12-31 | (m) | $-9.53M | (m) |
| 2019-09-30 | (m) | $-9.95M | (m) |
| 2019-06-30 | (m) | $-10.08M | (m) |
| 2019-03-31 | (m) | $-10.47M | (m) |
| 2018-12-31 | (m) | $-9.81M | (m) |
| 2018-09-30 | (m) | $-10.20M | (m) |
| 2018-06-30 | (m) | $-8.37M | (m) |
| 2018-03-31 | (m) | $-8.15M | (m) |
| 2017-12-31 | (m) | $-8.26M | (m) |
| 2017-09-30 | (m) | $-7.44M | (m) |
| 2017-06-30 | (m) | $-9.05M | (m) |
| 2017-03-31 | (m) | $-8.16M | (m) |
| 2016-12-31 | (m) | $-7.50M | (m) |
| 2016-09-30 | (m) | $-9.47M | (m) |
| 2016-06-30 | (m) | $-10.41M | (m) |
| 2016-03-31 | (m) | $-13.95M | (m) |
| 2015-12-31 | (m) | $-15.23M | (m) |
| 2015-09-30 | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) |
| 2014-12-31 | (m) | $-17.45M | (m) |
| 2013-12-31 | (m) | $-16.23M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |